ArticleThe journal of allergy and clinical immunology. Global2025
Vaccine hesitancy in an allergy and immunology clinic in an underserved community.
Article in The journal of allergy and clinical immunology. Global, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Allergy and immunology patients may be immunocompromised and at higher risk for infections. Identifying vaccine-hesitant groups is essential to protecting these individuals and those at risk in the community. Objective: We analyzed patient characteristics and factors associated with influenza and coronavirus disease 2019 (COVID-19) vaccine hesitancy in a clinic in a diverse community. Methods: Vaccination history and demographic information were collected as part of intake questionnaires from 338 new patients presenting to an outpatient allergy/immunology clinic from March 2023 to February 2024. Data were analyzed by Microsoft Excel and RStudio. Results: There were 94 men and 244 women (median [range] age, 41 [18-93] years). Ethnicities included 126 White (37.2%), 107 Hispanic (31.6%), 64 Asian (18.9%), and 41 Black (12.1%). English primary language speakers comprised 80% of the patient group. In this study, 39 subjects (11.54%) refused both influenza and COVID-19 vaccines; of these 39, the distribution in each category was as follows: 22 White (17.5%), 12 Hispanic (11.4%), 3 Asian (4.76%), and 2 Black (4.9%). Sex, age, and language were not significantly associated with vaccine refusal rate. Ethnicity was found to be significant. In our study, self-identified non-White patients were less likely to demonstrate vaccine hesitancy than the self-identified White patient group (odds ratio, 0.41; 95% confidence interval, 0.21-0.81). Conclusion: Many publications report minorities are more prone to vaccine hesitancy, hindering herd immunity. Odds ratios for refusal of both vaccines were lower for minorities in this studied population. Focusing efforts on all patients may enhance vaccination initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.